Biotech Values

[DewDiligence]

Confirming the statement in #msg-72102237 that Lipitor co-payments would sort themselves out when the 180-day Hatch-Waxman period ends this month:

http://online.wsj.com/article/SB10001424052702304543904577394263634380548.html

Independence Blue Cross, in the Philadelphia area, had assigned Lipitor its lowest, $14 co-pay for the first six months after limited generics entered the market. But after that first 180 days, when more generics will be allowed to enter the market, the plan will give that preferred status to a generic starting June 1 and Lipitor's co-pay will rise to about $45.

Regards, Dew